Overview

Atacand (Candesartan) Real Life Study

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This study is a Swedish historical cohort study in patients prescribed Atacand or Cozaar for hypertension by selected primary care centres. Data will be extracted anonymously from electronic medical records. In addition, data regarding morbidity and mortality will be collected by merging the cohort with the following national registries: the Hospital Discharge Register (SlutenvÄrdsregistret), the Cause of Death Register and the Heart Intensive Care Admission (RIKS-HIA)
Details
Lead Sponsor:
AstraZeneca
Treatments:
Candesartan
Candesartan cilexetil
Losartan